SCA
TNDM icon

Snowden Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Snowden Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6
Closed – – 1971
2021
Q4 		$0 Buy
+6
New +$810 ﹤0.01% 2152

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Snowden Capital Advisors's TNDM Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 6 shares.

Snowden Capital Advisors first reported a position in TNDM in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Snowden Capital Advisors reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 6 Tandem Diabetes Care shares in Q1 2022.
  • Snowden Capital Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 1 quarter.
  • Snowden Capital Advisors's Tandem Diabetes Care position peaked at $0 in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.